Ligand-induced cytoplasm to nucleus translocation is a critical event in the nuclear receptor (NR) signal transduction cascade. The development of green fluorescent proteins and their color variants fused with NRs, along with the recent developments in automated cellular imaging technologies, has provided unique tools to monitor and quantify the NR translocation events. These technology developments have important implications in the mechanistic evaluation of NR signaling and provide a powerful tool for drug discovery. The unique challenges for developing a robust NR translocation assay include cytotoxicity accompanied with chronic overexpression of NRs, basal translocation induced by serum present in culture medium, and interference from endogenous NRs, as well as subcellular dynamics. The authors have developed a robust assay system for the glucocorticoid receptor (GR) that was applied to a panel of nuclear receptor ligands. Using a high-content imaging system, ligand-induced, dose-dependent GR nuclear translocation was quantified and a correlation with other conventional assays established. (Journal of Biomolecular Screening 2007:1029-1041)
Mangelsdorf DJ, Thummel C., Beato M., Herlich P., Schutz G., Umesonn K., et al: The nuclear receptor superfamily: the second decade. Cell1995; 83:835-839.
2.
Gronemeyer H. , Gustafsson J., Laudet V.: Principles for modulation of the nuclear receptor superfamily. Nat Rev2004;3:950-964.
3.
Perissi V., Rosenfeld M.: Controlling nuclear receptors: the circular logic of cofactor cycles . Nat Rev2005;6:542-554.
4.
Chen T., Xie W., Agler M., Banks M.: Coactivators in assay design for nuclear hormone receptor drug discovery . Assay Drug Dev Tech2003;1: 835-842.
5.
Lin S., Bock CL, Gardner DB, Webster JC, Favata MF, Trzasko JM, et al: A high-throughput fluorescent polarization assay for nuclear receptor binding utilizing crude receptor extract. Anal Biochem2002;300:15-21.
6.
Parker GJ, Law TL, Lenoch FJ, Bolger RE: Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phophatase assays . J Biomol Screen2000;5:77-88.
7.
Glickman JF, Wu X., Mercuri R., Illy C., Bowen B., He Y., et al: A comparison of ALPHAScreen, TR-FRET and TRF as assay methods for FXR Nuclear Receptors. J Biomol Screen2002;7:3-10.
8.
Zhou, G., Cummings R., Hermes J., Moller D.: Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation. Methods2001 ;25:54-61.
9.
Grover GS, Turner BA, Parker CN, Meier J., Lala DS, Lee PH: Multiplexing nuclear receptors for agonist identification in a cell-based reporter gene high-throughput screen. J Biomol Screen2003;8:239-246.
Mohler ML, He Y., Wu A., Hong S., Miller DD: Dissociated non-steroidal glucocorticoids: tuning out untowards effects . Exp Opin Ther Patents2007;17:37-58.
12.
Kain SR: Green fluorescent protein (GFP): applications in cell-based assays for drug discovery. DDT1999;7:304-312.
13.
McNally JG, Muller WG, Walker D., Wolford R., Hager GL: The gluocorticoid receptor: rapid exchange with regularity sites in living cells. Science2000;287:1262-1265.
14.
Walker D., Htun H., Hager GL: Using inducible vectors to study intracellular trafficking of GFP-tagged steroid/nuclear receptors in living cells. Methods1999;19:386-393.
15.
Htun H., Barsony J., Renyi I., Gould DL, Hager CL: Visualization of glucocorticoid receptor translocation and intracellular organization in living cells with a green fluorescent protein chimera. Proc Natl Acad Sci USA1996;93:4845-4850.
16.
Nishi M., Ogawa H., Ito T., Matsuda K., Kawata M.: Dynamic changes in subcellular localization of mineralocorticoid receptors in living cells: in comparison with glucocorticoid receptor using dual-color labeling with green fluorescent spectral variants. Mol Endocrinol2001;15:1077-1092.
17.
Marcelli M. , Stenoien DL, Szafran AT, Simeoni S., Agoulnik IU, Weigel NL, et al: Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics and solubility . J Cell Biochem2006 ;98:770-788.
18.
Nishi M., Tanaka M., Matsuda K., Sunaguchi M., Kawata M.: Visualization of glucocorticoid receptor and mineralocorticoid receptor interactions in living cells with GFP-based fluorescence resonance energy transfer. J Neurosci2004;24:4918-4927.
19.
Htun H., Holth LT, Walker D., Davie JR, Hager GL: Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol Biol Cell1999;10:471-486.
20.
Taylor DL, Giuliano K.: Multiplexed high content screening assays create a systems cell biology approach to drug discovery. Drug Discov Today2005;2:149-154.
21.
Lang P., Yeow K., Nichols A., Scheer A.: Cellular imaging in drug discovery. Nat Rev/Drug Discov2006;5:343-356.
22.
Huizenga NATM , De Herder WW, Koper JW, de Lange P., v Lely DAJ, Brinkmann AO, et al: Decreased ligand affinity rather than glucocorticoid receptor down-regulation in patients with endogenous Cushing's syndrome. J Endocrinol2000;142:472-476.
23.
Heydorn A., Lundholt BK, Praestegaard M., Pagliaro L.: Protein translocation assays: key tools for accessing new biological information with high-throughput microscopy. Methods Enzymol2006;414:513-530.
24.
Olechno J., Ellson R., Browning B., Stearns R., Mutz M., Travis M., et al: Acoustic auditing as a real-time, non-invasive quality control process for both source and assay plates. Assay Drug Develop Tech2005;3:425-437.
25.
Funato H., Kobayashi A., Watanabe Y.: Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor. Brain Res2006;1117:125-134.
26.
Ding GJF , Fischer P., Boltz RC, Schmidt JA, Colaianne JJ, Gough A., et al: Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α. J Biol Chem1998;273:28897-28905.
27.
Nishi M., Takenaka N., Morita N., Ito T., Ozawa H., Kawata M.: Real-time imaging of glucocorticoid receptor dynamics in living neurons and glial cells in comparison with non-neural cells. Eur J Neurosci1999;11:1927-1936.
28.
Tanaka M., Nishi M., Morimoto M., Sugimoto T., Kawata M.: Imaging analysis of mineralocorticoid receptor and importins in single living cells by using GFP color variants. Cell Tissue Res2005;320:447-453.
29.
Fejes-Toth G., Pearce D., Naray-Fejes-Toth A: Subcellular localization of mineralocorticoid receptors in living cells: effects of receptor agonists and antagonists. Proc Natl Acad Sci USA1998 ;95:2973-2978.
30.
Tyagi RK, Lavrovsky Y., Ahn SC, Song CS, Chatterjee B., Roy AK: Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol2000;14:1162-1174.
31.
Pratt WB, Morishima Y., Murphy M., Harrell M.: Chaperoning of glucocorticoid receptors. HEP2006;172:111-138.
32.
Cheung J., Smith DF: Molecular chaperone interactions with steroid receptors: an update . Mol Endocrinol2000;14:939-949.
33.
Roe SM, Prodromou C., O'Brien R., Ladbury JE, Piper PW, Pearl LH: Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radcicol and geldanamycin. J Med Chem1999; 42:260-266.
34.
Czar MJ, Galigniana MD, Silverstein AM, Pratt WB: Geldanamycin, a heat shock protein 90-binding benzoquinone ansamycin, inhibits steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus. Biochem1997 ;36:7776-7785.
35.
Tago K., Tsukahara F., Naruse M., Yoshioka Y., Takano K.: Regulation of nuclear retention of glucocorticoid receptor by nuclear HSP90 . Mol Cell Endocrinol2004;213:131-138.
36.
Kakar M., Kanwal C., Davis JR, Li H., Lim CS: Geldanamycin, an inhibitor of Hsp90, blocks cytoplasmic retention of progesterone receptors and glucocorticoid receptors via their respective ligand binding domains. AAPS J2006;8:E718-E728.
37.
Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen1999;4:67-73.
38.
Fung P., Peng K., Kobel P., Dotimas H., Kauffman L., Olson K., et al: A homogeneous cell-based assay to measure nuclear translocation using βgalactosidase enzyme fragment complementation. Assay Drug Dev Tech2006;4:263-272.
39.
Pariante CM , Pearce BD, Pisell TL, Miller AH: The steroid receptor antagonist RU40555 and RU486 activate glucocorticoid receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. J Endocrinol2001;169:309-320.
40.
Hu X., Funder JW: The evolution of mineralocorticoid receptors. Mol Endocrinol2006;20:1471-1478.
41.
Takeda AN, Pinon GM, Bens M., Fagart J., Rafestin-Oblin ME, Vandewalle A.: The synthetic androgen methyltrienolone (R1881) acts as a potent antagonist of the mineralocorticoid receptor. Mol Pharm2007; 71:473-482.
42.
Buckingham J.: Glucocorticoids: exemplars of multi-tasking . Br J Pharm2006;147:S258-S268.
43.
Song LN, Coghlan M., Gelmann EP: Antiandrogen effects of mifepristone on coactivatior and corepressor interactions with the androgen receptor. Mol Endocrinol2004;18:70-85.
44.
Pilipuk GP, Vinson GP, Sanchez CG, Galigniana MD: Evidence for NL1-independent nuclear translocation of the mineralocorticoid receptor. Biochem2007;46:1389-1397.
45.
Martinez ED , Hager GL: Development of assays for nuclear receptor modulators using fluorescently tagged proteins. Methods Enzymol2006; 414:37-50.
46.
Garrett MD, Walton MI, McDonald E., Judson I., Workman P.: The contemporary drug development process: advances and challenges in pre-clinical and clinical development. Prog Cell Cycle Res2003;5:145-158.
47.
Moore K., Rees S.: Cell-based versus isolated target screening: how lucky do you feel?J Biomol Screen2001;6:69-74.
48.
Chen J., Lake MR, Sabet RS, Niforatos W., Pratt SD, Cassar SC, et al: Utility of large-scale transiently transfected cells for cell-based high throughput screens to identify transient receptor potential channel A1 antagonists. J Biomol Screen2007;12:61-69.
49.
Zhu Z., Puglish J., Connors D., Stewart J., Herbst J., Marino A., et al: Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay. J Biomol Screen2007;12:248-254.
Hager GL, Lim CS, Elbi C., Baumann CT: Trafficking of nuclear receptors in living cells. J Steroid Biochem Mol Biol2000;74:249-254.
52.
Berno V., Hinojos CA, Amazit L., Szafran AT, Mancini MA: High-resolution, high-throughput microscopy analyses of nuclear receptor coregulator function. Methods2006;414:188-210.
53.
Kino T., Tiulpakov A., Ichijo T., Chheng L., Kozasa T., Chrousos G.: G protein B interacts with the glucocorticoid receptor and suppresses it transcriptional activity in the nucleus. J Cell Biol2005;166:885-896.
54.
Ichijo T., Voutetakis A., Cotrim AP, Bhattachryya N., Fujii M., Chrousos GP, et al: The smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor. J Biol Chem2005;280:42067-42077.
55.
Takayama S. , Rogatsky I., Schwarcz LE, Darimont BD: The glucocorticoid receptor represses cyclin D1 by targeting the TCF-B-catenin complex. J Biol Chem2006;281:17856-17863.
56.
Yemelyanov A., Czwornog J., Chebotaev D., Karseladze A., Kulevitch E., Yang X.: Tumor suppressor activity of glucocorticoid receptor in the prostate. Oncogene2007;26:1885-1896.
57.
Haney SA, LaPan P., Pan J., Zhang J.: High-content screening moves to the front of the line. DDT2006;11:889-894.
